BIT.AX - Biotron Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue30/06/201930/06/201830/06/201730/06/2016
Total revenue1,072.8321,622.5841,659.4791,548.185
Cost of revenue----
Gross profit1,072.8321,622.5841,659.4791,548.185
Operating expenses
Research development1,115.8791,692.6563,155.4233,132.197
Selling general and administrative1,240.9371,277.2851,227.8171,175.153
Non-recurring----
Others404.488251.23386.216306.046
Total operating expenses2,773.7713,232.8134,782.534,628.853
Operating income or loss-1,700.939-1,610.229-3,123.051-3,080.668
Income from continuing operations
Total other income/expenses net89.1416.58429.64676.365
Earnings before interest and taxes-1,700.939-1,610.229-3,123.051-3,080.668
Interest expense----
Income before tax-1,611.799-1,593.645-3,093.405-3,004.303
Income tax expense----
Minority interest----
Net income from continuing ops-1,611.799-1,593.645-3,093.405-3,004.303
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income-1,611.799-1,593.645-3,093.405-3,004.303
Preferred stock and other adjustments----
Net income applicable to common shares-1,611.799-1,593.645-3,093.405-3,004.303